Trial Profile
A Study to Determine the Ability of Folate Conjugates to Target Folate Receptors in Ovarian Cancer Tumors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs Technetium Tc99m etarfolatide (Primary)
- Indications Ovarian cancer
- Focus Diagnostic use
- Sponsors Endocyte
- 21 Nov 2014 New trial record